This removes insurance intermediaries and allows patients to view transparent pricing upfront
The Vyleesi prescribing information reports nausea in 40% of patients, against 1.3% on placebo
It skips the fermentation phase of the lower digestive tract, so there is no need to worry about it causing small intestinal bacterial overgrowth (SIBO) or Candida infections
When you follow a meticulous reconstitution protocol with a peptide you can trust, you are setting your project up for success
A GLP-1-secreting intestinal L-cell line, GLUTag cells, were also prepared
Twelve percent believe that their employees level of concern over the complexity of prior authorization requirements is high, 32% believe the level of concern is moderate, 31% believe the level of concern is low, 16% believe the level of concern is none, and 9% do not know the level of concern [Figure I]